Genomic Unity® Prenatal Analysis

Conditions considered:

 Condition Gene(s)
Yunis-Varon syndromeFIG4
XFE progeroid syndromeERCC4
Xeroderma pigmentosum, group G / Cockayne syndromeERCC5
Xeroderma pigmentosum, group F / Cockayne syndromeERCC4
Xeroderma pigmentosum, group DERCC2
Xeroderma pigmentosum, group CXPC
Xeroderma pigmentosum, group BERCC3
Xeroderma pigmentosum, group AXPA
X-linked intellectual disability, Stocco Dos Santos typeSHROOM4
X-linked intellectual disability, Snyder typeSMS
X-linked intellectual disability, Cabezas typeCUL4B
X-linked intellectual disability-hypotonic face syndromeATRX
X-linked intellectual disability-cerebellar hypoplasia syndrome / Oligophrenin-1 (OPHN1) syndromeOPHN1
X-linked intellectual disability with marfanoid habitus / Lujan-Fryns syndromeHUWE1
X-linked intellectual disability with marfanoid habitus / Lujan-Fryns syndromeZDHHC9
X-linked intellectual disability with isolated growth hormone deficiencySOX3
X-linked intellectual disability syndromeFGD1, MECP2, UPF3B, RPL10
Wrinkly skin syndromeATP6V0A2
Wolman diseaseLIPA
Wolcott-Rallison syndromeEIF2AK3
Wiskott-Aldrich syndromeWAS
Wilson diseaseATP7B
Wilms tumor, type 1WT1
Wieacker-Wolff syndromeZC4H2
Werner syndromeWRN
Weill-Marchesani syndromeFBN1
Watson syndromeNF1
Warfarin sensitivityF9
Waardenburg syndrome, type 4AEDNRB
Waardenburg syndrome, type 2E, 4CSOX10
Waardenburg syndrome, type 2ATYR
Waardenburg syndrome, type 2AMITF
Waardenburg syndrome, type 1, 3PAX3
von Willibrand disease, multiple typesVWF
von Willebrand disease, Platelet-typeGP1BA
von Hippel-Lindau syndromeVHL
Vohwinkel syndromeGJB2
Vitamin D-dependent rickets, type ICYP27B1
Visceral heterotaxyCFC1
Very long-chain acyl-CoA dehydrogenase deficiencyACADVL
Ventricular septal defectGATA4, NKX2-5
Ventricular fibrillation, paroxysmal familialSCN5A
van der Woude syndromeIRF6
Van Buchem diseaseSOST
VACTERL associationZIC3
Usher syndrome, type D, 1D/FCDH23
Usher syndrome, type 3ACLRN1
Usher syndrome, type 2AUSH2A
Usher syndrome, type 1GUSH1G
 Condition Gene(s)

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: